Nortech Systems Incorporated reported a 36% surge in medical-device revenue during its second-quarter 2026 financial results [1].
The growth in the medical sector and a rising backlog suggest a strengthening demand for the company's specialized systems amidst a broader push for healthcare technology updates.
Net sales for the quarter rose 9.3% to $33.5 million [3], according to company data. This growth was accompanied by a 25.8% year-over-year increase in the company's backlog [1]. The total orders currently sitting in the backlog reached $93.8 million [3].
Chief Financial Officer Andrew LaFrence said that net income for the period was $316,000, which equates to $0.11 per diluted share [3]. "Net income was $316,000, or $0.11 per diluted share," LaFrence said [3].
Liquidity remains tight as the company manages its growth. Nortech reported having $1.7 million in cash and restricted cash [3]. To support operations, the company has utilized $7.6 million in borrowings from its revolving credit facility [3].
Financial reports also detailed specific compensation adjustments. The company recorded management incentive compensation expense of $647,000 [8]. This follows a prior year reversal of $527,000 [9].
Executives discussed these figures during a virtual earnings call held on Aug. 12 [10]. The call served as a platform to outline the strength of the current order pipeline, and provide updated guidance to investors [1, 3].
“Medical-device revenue surged 36%”
The disparity between Nortech's massive order backlog and its relatively low cash reserves indicates a company in a scaling phase. While the 36% jump in medical-device revenue shows strong market fit, the reliance on a $7.6 million credit facility suggests that the company is borrowing to fund the production required to clear its $93.8 million backlog.
